Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Combined Treatment of Intravitreous Bevacizumab and Triamcinolone for the Treatment or Macular Edema Secondary to Central Retinal Vein Occlusion

Treatment of macular edema secondary to central retinal vein occlusion is more effective with combined therapy of bevacizumab and triamcinolone than bevacizumab alone.

Comparison of two groups with different treatment with registrations of outcome in BCVA and complications

Inclusion Criteria:

• Macular edema secondary to central retinal vein occlusion
• BCVA worse than 20/40
• Central macular >250 mc with OCT

Exclusion Criteria:

• Diabetic retinopathy or other retinopathy
• Media opacity that does not allow following
• steroid responder
• diagnosed glaucoma or IOP > 21 mmHg